Suggested risk factor for oral lichen planus arising after mRNA COVID‐19 vaccination
A single dose of BNT162b2 vaccine is suggested for COVID‐19‐infected individuals to reduce side effects due to release of inflammatory mediators such as oral lichen planus (OLP).
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-07-01
|
| Series: | Clinical Case Reports |
| Online Access: | https://doi.org/10.1002/ccr3.6126 |